November 10, 2022
On November 10, 2022, Dr. Brian Becker provided direct, cross-examination, and “hot tub” testimonies regarding royalty damages in the biopharmaceutical industry at the American Arbitration Association.
On November 10, 2022, Dr. Brian Becker provided direct, cross-examination, and “hot tub” testimonies regarding royalty damages in the biopharmaceutical industry at the American Arbitration Association.
On October 14, 2022, Dr. Brian Becker served as a panelist for the “Using Experts in State Tax Matters” at the ABA Tax Section 2022 Fall Meeting.
On June 15, 2022, Dr. Brian Becker submitted a damages expert report involving a powerplant in Madagascar in an international arbitration dispute at the International Centre for Dispute Resolution.
On June 1, 2022, Dr. Brian Becker submitted an expert report to the Central District Court of California concerning class-action damages for fund investments. On July 13, 2022, Dr. Brian Becker provided a deposition testimony for the same case.
On May 13, 2022, Dr. Brian Becker provided an expert report dealing with class-action damages to the United States District Court in Southern Ohio in a dispute about the management of an investment fund.
On May 11, 2022, Dr. Brian Becker provided an expert report assessing royalty damages in the biopharmaceutical industry to the American Arbitration Association.
On March 1, 2022, Dr. Brian Becker provided direct and cross-examination testimony (virtually) to JAMS Arbitration in a case concerning unfair competition.
On January 10, 2022, Dr. Brian Becker provided direct and cross-examination testimony (virtually) to the Southern District Court of New York in suit regarding the management of retirement funds.
On January 7, 2022, Dr. Brian Becker provided a rebuttal expert report to the United States Tax Court in the Western Digital Corporation transfer pricing dispute.
NFP knocks back all claims against it, but some charges filed against the plan fiduciary defendants and flexPATH will now go to trial.
An Illinois jury said Eli Lilly and Co. must pay $61 million in a whistleblower’s fraud suit alleging that the company made false claims about pricing under Medicaid’s drug rebate program.
Global headhunter Egon Zehnder allegedly cheated the city and the state of New York out of millions under a 10-year tax dodge designed to underreport U.S.-based earnings while ginning up illegitimate losses, according to a recently unsealed tax whistleblower complaint.
Western Digital, a Nasdaq-listed Silicon Valley data storage giant, is challenging a $516 million (€449 million) tax bill from US authorities over its alleged use of Irish subsidiaries in its global tax planning.
Energy giant ExxonMobil is suing NorthWestern Energy over power outages at its Billings refinery. Exxon claims the outages cost the company millions of dollars.
Swiss pharma giant Roche faces a $60 million tax adjustment after the first court decision involving Australia’s complex transfer pricing rules, which are designed to ensure multinationals pay their fair share of tax.